1. "1996"
Formats
  1. Journal Article (1065)
  2. Meeting Abstract (367)
  3. Book Section (77)
  4. Conference Paper (58)
  5. Book Whole (7)
Groups
  1. Sloan Kettering Institute Faculty (359)
  2. Department of Medicine (296)
  3. GSK Faculty (273)
  4. Surgery (211)
  5. Molecular Pharmacology and Chemistry Program Faculty (168)
  6. Solid Tumor Oncology Division (153)

More Groups

People
  1. Murray Brennan (31)
  2. William Fair (28)
  3. Howard Scher (27)
  4. Malcolm Moore (27)
  5. Michael Burt (27)
  6. Joseph Bertino (26)

More People

Years
  1. 1996 (1574)
Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (96)
  2. Blood (74)
  3. Journal of Biological Chemistry (42)
  4. Journal of Clinical Oncology (41)
  5. International Journal of Radiation Oncology, Biology, Physics (32)
  6. Laboratory Investigation (28)

More Publications

Publishers
  1. Elsevier Inc. (163)
  2. American Association for Cancer Research (140)
  3. Lippincott Williams & Wilkins (81)
  4. Nature Publishing Group (80)
  5. Elsevier Science, Inc. (77)
  6. American Society of Hematology (74)

More Publishers

Results (1574)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prognostic model for advanced Hodgkin's disease (HD) at M.D. Anderson (MDA) validated with an independent set of patients treated at Memorial Sloan-Kettering (MSK)
    Meeting Abstract

    Sarris, A. H.; Straus, D.; Preti, A.; Smith, T.; Myers, J.; Hess, M.; Pugh, W.; Cabanillas, F.
    Blood (1996)

    Fulltext@MSK | Save
  • Targeted disruption of the PLZF gene of acute promyelocytic leukemia results in phocomelia and altered spermatogenesis
    Meeting Abstract

    Hawe, N.; Soares, V.; Niswander, L.; Cattoretti, G.; Pandolfi, P. P.
    Blood (1996)

    Fulltext@MSK | Save
  • Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Berman, E.; Tyson, D.; Scheinberg, D.
    Blood (1996)

    Fulltext@MSK | Save
  • High-dose infusional humanized anti-CD33 M195: Prospects for treating minimal disease in myeloid leukemia
    Meeting Abstract

    Caron, P. C.; Jurcic, J. G.; Dumont, L.; Tyson, D.; Scheinberg, D. A.
    Blood (1996)

    Fulltext@MSK | Save
  • Initial clinical study of a novel organic arsenical, melarsoprol, in patients with advanced leukemia
    Meeting Abstract

    Soignet, S.; Tong, W. P.; Gabrilove, J.; Scheinberg, D. A.; Pandolfi, P. P.; Warrell, R. P. Jr
    Blood (1996)

    Fulltext@MSK | Save
  • In-vitro and in-vivo anti-leukemic activity of a natural killer (NK) cell clone against both primary human leukemias and leukemic cell lines
    Meeting Abstract

    Yan, Y.; McGuirk, J.; Steinherz, P.; O'Reilly, R. J.
    Blood (1996)

    Fulltext@MSK | Save
  • Reduced acute and chronic graft versus host disease (GVHD) do not compromise leukemia free survival following T-cell depleted (SBA "E") unrelated marrow transplants for pediatric acute lymphoblastic leukemia
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Gillio, A.; Small, T.; Van Syckle, K.; Szabolcs, P.; Collins, N. H.; Yang, S. Y.; Landrey, C.; Mitchell-Grant, J.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol
    Meeting Abstract

    Noy, A.; Verma, R.; Rahman, Z. U.; Glenn, M.; Maslak, P.; Weiss, M.; Zelenetz, A. D.
    Blood (1996)

    Fulltext@MSK | Save
  • Effect of G-CSF and GM-CSF on multidrug resistant (MDR) leukemia cells
    Meeting Abstract

    Berman, E.; McBride, M.
    Blood (1996)

    Fulltext@MSK | Save
  • Adenoviral mediated gene transfer into ex vivo expanded megakaryocytic, myeloid and erythroid precursors
    Meeting Abstract

    Frey, B. M.; Hackett, N.; Mohle, R.; Moore, M. A. S.; Crystal, R. G.; Rafii, S.
    Blood (1996)

    Fulltext@MSK | Save